[논문]Phage Display 기법을 이용한 B형 간염 바이러스 Polymerase의 RNase H 활성을 억제하는 인간 단세포군 항체의 개발

이성락; 송은경; 정영주; 이영이; 김익중; 최인학; 박세광

doi:10.4110/in.2004.4.1.16

[국내논문] Phage Display 기법을 이용한 B형 간염 바이러스 Polymerase의 RNase H 활성을 억제하는 인간 단세포군 항체의 개발
Development of Human Antibody Inhibiting RNase H Activity of Polymerase of Hepatitis B Virus Using Phage Display Technique 원문보기

Immune network : official journal of the Korean association of immunobiologists, v.4 no.1, 2004년, pp.16 - 22

이성락 (인제대학교 의과대학 미생물학교실) , 송은경 (인제대학교 의과대학 미생물학교실) , 정영주 (인제대학교 의과대학 미생물학교실) , 이영이 (동국대학교 의과대학 미생물학교실) , 김익중 (동국대학교 의과대학 미생물학교실) , 최인학 (인제대학교 의과대학 미생물학교실) , 박세광 (인제대학교 의과대학 미생물학교실, 인제대학교 백인제기념임상의학연구소 세포유전자치료연구부)

Abstract ▼ AI-Helper

Background: To develop a novel treatment strategy for hepatitis B virus infection, a major cause of liver chirosis and cancer, we aimed to make human monoclonal antibodies inhibiting RNase H activity of P protein playing in important role in HBV replication. In this regard, phage display technology was employed and demonstrated as an efficient cloning method for human monoclonal antibody. So this study analysed the usability of human monoclonal antibody as protein based gene therapy. Methods: RNase H of HBV was expressed as fusion protein with maltose binding protein and purified with amylose resin column. Single chain Fv (scFv) phage antibody library was constructed by PCR cloning using total RNAs of PBMC from 50 healthy volunteers. Binders to RNase H were selected with BIAcore 2000 from the constructed library, and purified as soluble antibody fragment. The affinity and sequences of selected antibody fragments were analyzed with BIAcore and ABI automatic sequencer, respectively. And finally RNase H activity inhibiting assay was carried out. Results: Recombinant RNase H expressed in E. coli exhibited an proper enzyme activity. Naive library of $4.46{\times}10^9cfu$ was screened by BIAcore 2000. Two clones, RN41 and RN56, showed affinity of $4.5{\times}10^{-7}M$ and $1.9{\times}10^{-7}M$, respectively. But RNase H inhibiting activity of RN41 was higher than that of RN56. Conclusion: We cloned human monoclonal antibodies inhibiting RNase H activity of P protein of HBV. These antibodies can be expected to be a good candidate for protein-based antiviral therapy by preventing a replication of HBV if they can be expressed intracellularly in HBV-infected hepatocytes.

Keyword

참고문헌 (32)

Lau JY, Wright TL: Molecular virology and pathogenesis of hepatitis B. Lancet 342;1335-1340, 1993

상세보기
Ganem D: Hepadnaviridae and their replication. In: Fields BN eds.: Fields virology 3rd ed. p1199-1233, Philadelphia Lippincott-Raven, 1996.
Wong DK, Cheung AM, O'Rourke K, Naylor CD, Detsky AS, Heathcote J: Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis. Ann Intern Med 119;312-323, 1993

상세보기
Perrillo RP, Schiff ER, Davis GL, Bodenheimer HC, Jr., Lindsay K, Payne J: A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group. N Engl J Med 323;295-301, 1990

상세보기
Krogsgaard K, Bindslev N, Christensen E, Craxi A, Schlichting P, Schalm S: The treatment effect of alpha interferon in chronic hepatitis B is independent of pre-treatment variables. Results based on individual patient data from 10 clinical controlled trials. European Concerted Action on Viral Hepatitis (Eurohep). J Hepatol 21;646-655, 1994

상세보기
Lai CL, Ching CK, Tung AK, Li E, Young J, Hill A: Lamivudine is effective in Suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: a placebo-controlled trial. Hepatology 25;241-244, 1997

상세보기
Bartholomew MM, Jansen RW, Jeffers LJ, Reddy KR, Johnson LC, Bunzendahl H, Condreay LD, Tzakis AG, Schiff ER, Brown NA: Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Lancet 4;349:20-22, 1997

상세보기
Tipples GA, Ma MM, Fischer KP, Bain VG, Kneteman NM, Tyrrell DL: Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo. Hepatology 24;714-717, 1996
Blum HE, Galun E, von Weizsacker F, Wands JR: Inhibition of hepatitis B virus by antisense oligodeoxynucleotides. Lancet 337;1230, 1991
Offensperger WB, Offensperger S, Walter E, Teubner K, Igloi G, Blum HE, Gerok W: In vivo inhibition of duck hepatitis B virus replication and gene expression by phosphorothioate modified antisense oligodeoxynucleotides. EMBO J 12;1257-1262, 1993

상세보기
Carman W, Thomas H, Domingo E: Viral genetic variation:hepatitis B virus as a clinical example. Lancet 341;349-353, 1993

상세보기
von Weizsacker F, Wieland S, Kock J, Offensperger WB, Offensperger S, Moradpour D: Gene therapy for chronic viral hepatitis: ribozymes, antisense oligonucleotides, and dominant negative mutants. Hepatology 26;251-255, 1997

상세보기
Winter G, Milstein C: Man-made antibodies. Nature 349;293-299, 1991

상세보기
McCafferty J, Griffiths AD, Winter G, Chiswell DJ: Phage antibodies: filamentous phage displaying antibody variable domains. Nature 348;552-554, 1990

상세보기
Bird RE, Hardman KD, Jacobson JW, Johnson S, Kaufman BM, Lee SM: Single-chain antigen-binding proteins. Science 242;423-426, 1998.
Radziwill G, Tucker W, Schaller H. Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity. J Virol 64;613-620, 1990

상세보기
Barbas CF III, Burton DR, Scott JK, Silverman GJ: Phage display, a laboratory manual. p9.23-11.15 CSHL press, 2001
Tsurimoto T, Fujiyama A, Matsubara K: Stable expression and replication of hepatitis B virus genome in an integrated state in a human hepatoma cell line transfected with the cloned viral DNA. Proc Natl Acad Sci USA 84:444-448, 1987

상세보기
Jeong JH, Kwak DS, Rho HM, Jung G: The catalytic properties of human hepatitis B virus polymerase. Biochem Biophys Res Commun 223:264-271, 1996

상세보기
Seifer M, Standring DN: Recombinant human hepatitis B virus reverse transcriptase is active in the absence of the nucleocapsid or the viral replication origin, DR1. J Virol 67;4513-4520, 1993
Winter G, Harris WJ: Humanized antibody. Immunol Today 14;139-143, 1993
Andrzejewski C, Young PJ, Goldman J: Production of human IgM warm reacting red cell monoclonal autoantibodies by Epstein-Barr virus transformation. Transfusion 101;196-202, 1989
Lonberg N, Taylor LD, Harding FA: Antigen-specific human antibodies from mice comprising four distinct modifications. Nature 368;856-859, 1994

상세보기
Winter G, Griffiths AD, Hawkins RE: Making antibodies by phage display technology. Ann Rev Immunol 12:433-455, 1994

상세보기
Marks JD, Hoogenboom HR, Bonnert TP, McCafferty J, Griffiths AD, Winter G: By-passing immunization. Human antibodies from V-gene libraries displayed on phage. J Mol Biol 222;581-597, 1991

상세보기
Clackson T, Hoogenboom HR, Griffiths AD, Winter G: Making antibody fragments using phage display libraries. Nature 352:624-628, 1991.

상세보기
Griffiths AD, Williams SC, Hartley O, Tomlinson IM, Waterhouse P, Crosby WL: Isolation of high affinity human antibodies directly from large synthetic repertoires. EMBO J 13;3245-3260, 1994.

상세보기
Malmborg AC, Duenas M, Ohlin M, Soderlind E, Borrebaeck CA: Selection of binders from phage displayed antibody libraries using the BIAcore biosensor. J Immunol Methods 198;51-57, 1996

상세보기
Hawkins RE, Russell SJ, Winter G: Selection of phage antibodies by binding affinity. Mimicking affinity maturation. J Mol Biol 226;889-896, 1992

상세보기
Bradbury A, Persic L, Werge T, Cattaneo A: Use of living columns to select specific phage antibodies. Biotechnology (NY) 11;1565-1569, 1993

상세보기
Cai X, Garen A: Anti-melanoma antibodies from melanoma patients immunized with genetically modified autologous tumor cells: selection of specific antibodies from single-chain Fv fusion phage libraries. Proc Natl Acad Sci USA 92;6537-6541, 1995

상세보기
Van Ewijk W, de Kruif J, Germeraad WT, Berendes P, Ropke C, Platenburg PP, Logtenberg T: Subtractive isolation of phage-displayed single-chain antibodies to thymic stromal cells by using intact thymic fragments. Proc Natl Acad Sci USA 94;3903-3908, 1997

상세보기

내보내기 구분	파일저장 인쇄 메일전송
구성항목	기본정보 상세정보 관리번호, 논문명, 저널/프로시딩명, 저자 , 발행년, 권, 호, 시작페이지, 끝페이지, 발행기관 관리번호, 논문명, 대등논문명, 저자 , 저널/프로시딩명, 발행기관, 발행년, 발행언어, 권, 호, 시작페이지, 끝페이지, ISBN, ISSN, 주제분야, 키워드, 초록(한글), 초록(영문), 저자(소속기관)
저장형식	Text(ASCII format) Excel format RefWorks Direct Export RIS format (for Reference Manager, ProCite, EndNote), Scholar's Aids, Mendeley
메일정보	받는사람 (필수) @ 보내는사람 (선택) @ 제목 내용 KISTI 검색결과 이메일 서비스
안내	총 건의 자료가 검색되었습니다. 다운받으실 자료의 인덱스를 입력하세요. (1-10,000) 검색결과의 순서대로 최대 10,000건 까지 다운로드가 가능합니다. 데이타가 많을 경우 속도가 느려질 수 있습니다.(최대 2~3분 소요) 다운로드 파일은 UTF-8 형태로 저장됩니다. 파일의 내용이 제대로 보이지 않을실 때는 웹브라우저 상단의 보기 -> 인코딩 -> 자동선택 여부를 확인하십시오. ~ Text(ASCII format) Excel format

연합인증

[국내논문] Phage Display 기법을 이용한 B형 간염 바이러스 Polymerase의 RNase H 활성을 억제하는 인간 단세포군 항체의 개발
Development of Human Antibody Inhibiting RNase H Activity of Polymerase of Hepatitis B Virus Using Phage Display Technique 원문보기

Abstract ▼ AI-Helper

Keyword

참고문헌 (32)

이 논문을 인용한 문헌

저자의 다른 논문 :

관련 콘텐츠

원문 보기

원문 URL 링크

오픈액세스(OA) 유형

연관된 기능

이 논문과 함께 이용한 콘텐츠

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

선택된 텍스트

연합인증

[국내논문] Phage Display 기법을 이용한 B형 간염 바이러스 Polymerase의 RNase H 활성을 억제하는 인간 단세포군 항체의 개발 Development of Human Antibody Inhibiting RNase H Activity of Polymerase of Hepatitis B Virus Using Phage Display Technique 원문보기

Abstract ▼ AI-Helper

Keyword

참고문헌 (32)

이 논문을 인용한 문헌

저자의 다른 논문 :

(1) (5) (2)

관련 콘텐츠

원문 보기

원문 URL 링크

오픈액세스(OA) 유형

연관된 기능

이 논문과 함께 이용한 콘텐츠

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

선택된 텍스트

[국내논문] Phage Display 기법을 이용한 B형 간염 바이러스 Polymerase의 RNase H 활성을 억제하는 인간 단세포군 항체의 개발
Development of Human Antibody Inhibiting RNase H Activity of Polymerase of Hepatitis B Virus Using Phage Display Technique 원문보기